第 1 到 11 筆結果,共 11 筆。
公開日期 | 標題 | 作者 | 來源出版物 | scopus | WOS | 全文 | |
---|---|---|---|---|---|---|---|
1 | 2022 | The risk of subsequent malignancies in patients with renal cell carcinoma: A nationwide, population-based study | Lu, Yu Cheng; YU-CHIEH TSAI ; PO-MING CHOW ; Weng, Wen Ching; Huang, Wei Yi; SHIH-CHIEH CHUEH ; KAO-LANG LIU ; KUO-HOW HUANG | Urological Science | 0 | 0 | |
2 | 2019 | Correction to: Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma (Journal of Molecular Medicine, (2018), 96, 12, (1307-1318), 10.1007/s00109-018-1697-7) | WEI-CHOU LIN ; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU ; CHIA-TUNG SHUN ; Shi C.-S.; HONG-CHIANG CHANG ; YU-CHIEH TSAI ; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW ; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG | Journal of Molecular Medicine | 1 | 1 | |
3 | 2018 | Trichostatin A, a histone deacetylase inhibitor, induces synergistic cytotoxicity with chemotherapy via suppression of Raf/MEK/ERK pathway in urothelial carcinoma | WEI-CHOU LIN ; Hsu F.-S.; Kuo K.-L.; SHING-HWA LIU ; CHIA-TUNG SHUN ; Shi C.-S.; HONG-CHIANG CHANG ; YU-CHIEH TSAI ; Lin M.-C.; Wu J.-T.; Kuo Y.; PO-MING CHOW ; Liao S.-M.; Yang S.-P.; Hong J.-Y.; KUO-HOW HUANG | Journal of Molecular Medicine | 8 | 9 | |
4 | 2015 | MLN4924, a novel protein neddylation inhibitor, suppresses proliferation and migration of human urothelial carcinoma: In vitro and in vivo studies | Kuo K.-L.; Ho I.-L.; Shi C.-S.; Wu J.-T.; WEI-CHOU LIN ; YU-CHIEH TSAI ; HONG-CHIANG CHANG ; Chou C.-T.; Hsu C.-H.; Hsieh J.-T.; Chang S.-C.; YEONG-SHIAU PU ; KUO-HOW HUANG | Cancer Letters | 48 | 51 | |
5 | 2015 | MLN4924 synergistically enhances cisplatin-induced cytotoxicity via jnk and bcl-xl pathways in human urothelial carcinoma | Ho I.-L.; Kuo K.-L.; Liu S.-H.-.; HONG-CHIANG CHANG ; Hsieh J.-T.; Wu J.-T.; CHIH-KANG CHIANG ; WEI-CHOU LIN ; YU-CHIEH TSAI ; Chou C.-T.; Hsu C.-H.; YEONG-SHIAU PU ; Shi C.-S.; KUO-HOW HUANG | Scientific Reports | 35 | 35 | |
6 | 2015 | Ureteral involvement and diabetes increase the risk of subsequent bladder recurrence after nephroureterectomy for upper urinary tract urothelial carcinoma | Hu C.-Y.; YU-CHIEH TSAI ; SHUO-MENG WANG ; CHAO-YUAN HUANG ; Tai H.-C.; CHUNG-HSIN CHEN ; YEONG-SHIAU PU ; WEI-CHOU LIN ; KUO-HOW HUANG | BioMed Research International | 7 | 3 | |
7 | 2012 | Down-regulation of glucose-regulated protein (GRP) 78 potentiates cytotoxic effect of celecoxib in human urothelial carcinoma cells | KUO-HOW HUANG ; Kuo K.-L.; Chen S.-C.; TE-I WENG ; Chuang Y.-T.; YU-CHIEH TSAI ; YEONG-SHIAU PU ; CHIH-KANG CHIANG ; Liu S.-H. | PLoS ONE | 34 | 27 | |
8 | 2009 | Induction Cisplatin and Fluorouracil-Based Chemotherapy Followed by Concurrent Chemoradiation for Muscle-Invasive Bladder Cancer | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHIA-HSIEN CHENG ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; Feng-Ming Hsu ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU | International Journal of Radiation Oncology Biology Physics | 27 | 22 | |
9 | 2007 | Gemcitabine and ifosfamide as a second-line treatment for cisplatin-refractory metastatic urothelial carcinoma: A phase II study | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; Keng H.-Y.; YU-CHIEH TSAI ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU | Anti-Cancer Drugs | 32 | 29 | |
10 | 2007 | Prognostic Factors for Metastatic Urothelial Carcinoma Treated with Cisplatin and 5-Fluorouracil-Based Regimens | CHIA-CHI LIN ; CHIH-HUNG HSU ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; KUO-HOW HUANG ; ANN-LII CHENG ; YEONG-SHIAU PU | Urology | 24 | 21 | |
11 | 2007 | Stopping smoking might reduce tumour recurrence in nonmuscle-invasive bladder cancer | CHUNG-HSIN CHEN ; CHIA-TUNG SHUN ; KUO-HOW HUANG ; CHAO-YUAN HUANG ; YU-CHIEH TSAI ; HONG-JENG YU ; YEONG-SHIAU PU | BJU International | 101 | 87 |